Reckitt Benckiser shells $1.4B to settle US probe; NICE backs diabetes, psoriasis treatments
→ British group Reckitt Benckiser (RB) has agreed to pay the US Department of Justice (DoJ) and the Federal Trade Commission $1.4 billion to resolve …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
